Development of Stereotactic Mass Spectrometry for Brain Tumor Surgery | Zendy

Nathalie Y.R. Agar | Zendy; Alexandra J. Golby | Zendy; Keith L. Ligon | Zendy; Isaiah Norton | Zendy; Vandana Mohan | Zendy; Justin M. Wiseman | Zendy; Allen Tannenbaum | Zendy; Ferenc A. Jólesz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Development of Stereotactic Mass Spectrometry for Brain Tumor Surgery

Author(s) -

Nathalie Y.R. Agar,

Alexandra J. Golby,

Keith L. Ligon,

Isaiah Norton,

Vandana Mohan,

Justin M. Wiseman,

Allen Tannenbaum,

Ferenc A. Jólesz

Publication year - 2010

Publication title -

neurosurgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.485

H-Index - 34

eISSN - 1081-1281

pISSN - 0148-396X

DOI - 10.1227/neu.0b013e3181ff9cbb

Subject(s) - medicine , mass spectrometry imaging , mass spectrometry , radiology , brain tumor , pathology , chromatography , chemistry

Surgery remains the first and most important treatment modality for the majority of solid tumors. Across a range of brain tumor types and grades, postoperative residual tumor has a great impact on prognosis. The principal challenge and objective of neurosurgical intervention is therefore to maximize tumor resection while minimizing the potential for neurological deficit by preserving critical tissue.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research